Doctor profile · Federal record
Dr. Shruti Singh, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Dyer, IN
- NPI 1619210143
- Accepts Medicare
- 13 yrs in practice
- Licensed in 2 states
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1001 Calumet Ave
Dyer, IN 463111596
(219) 924-8178
fax (219) 924-8179
Credentials & registration
- NPI registered
- April 2013 — 13 yrs on file
- Profile last updated
- March 17, 2021
- Year of graduation
- 2013 — 13 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Indiana #01082844A · Illinois #125.063191
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1619210143. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
65,730
Distinct HCPCS
10
Medicare allowed
$1,355,098
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9025 |
Injection, azacitidine, 1 mg | 17,000 | 17 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 12,600 | 17 | $54 | |
J0185 |
Injection, aprepitant, 1 mg | 5,070 | 25 | $2 | |
J1437 |
Injection, ferric derisomaltose, 10 mg | 4,100 | 36 | $21 | |
J9267 |
Injection, paclitaxel, 1 mg | 2,972 | 13 | $0 | |
J1449 |
Injection, eflapegrastim-xnst, 0.1 mg | 2,640 | 13 | $31 | |
36415 |
Insertion of needle into vein for collection of blood sample | 1,008 | 235 | $8 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 979 | 228 | $8 | |
82040 |
Albumin (protein) level | 967 | 226 | $5 | |
82247 |
Bilirubin level, total | 967 | 226 | $5 |
In context: peer comparison
Among 3 peers in Dyer Hematology & Oncology Physician, average services per provider: 2,510. This provider delivers 26× the peer median.Open Payments
Industry payments received
All-time total
$42,982
Transactions
141
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 29 | $13,203.74 | |
| Daiichi Sankyo INC. | 14 | $11,719.60 | |
| AstraZeneca Pharmaceuticals Lp | 25 | $11,073.78 | |
| BeiGene USA, INC. | 6 | $4,350.09 | |
| Abbott Laboratories | 7 | $631.64 | |
| Sobi, INC | 5 | $274.64 | |
| Novartis Pharmaceuticals Corporation | 10 | $223.99 | |
| Gilead Sciences, INC. | 8 | $150.49 | |
| Celgene Corporation | 9 | $149.53 | |
| Genmab U.S., INC. | 6 | $138.00 | |
| Abbvie INC. | 6 | $106.92 | |
| GlaxoSmithKline, LLC. | 4 | $95.22 | |
| Merck Sharp & Dohme LLC | 4 | $92.70 | |
| Genentech USA, INC. | 4 | $87.68 | |
| Pfizer INC. | 4 | $84.03 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
278
Patients
69
Total drug cost
$971,935
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 56 | 19 | $3,134 |
| Ondansetron Hcl | Generic | 38 | 24 | $1,313 |
| Acyclovir | Generic | 31 | 0 | $657 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 28 | 0 | $443,674 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 20 | 13 | $740 |
| Xarelto (Rivaroxaban) | Brand | 20 | 0 | $33,071 |
| Dexamethasone | Generic | 19 | 13 | $524 |
| Ibrance (Palbociclib) | Brand | 18 | 0 | $304,811 |
| Venclexta (Venetoclax) | Brand | 14 | 0 | $14,945 |
| Tavalisse (Fostamatinib Disodium) | Brand | 12 | 0 | $168,518 |
Hospital affiliations
Frequently asked questions
What is Dr. Shruti Singh's medical specialty?
Dr. Shruti Singh practices Hematology & Oncology Physician in Dyer, IN.
Where does Dr. Shruti Singh practice?
Dr. Shruti Singh practices at 1001 Calumet Ave, Dyer, IN 463111596. Office phone: 2199248178.
What is Dr. Shruti Singh's NPI?
Dr. Shruti Singh's National Provider Identifier (NPI) is 1619210143, issued by NPPES.
Does Dr. Shruti Singh accept Medicare assignment?
Yes. Dr. Shruti Singh accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Shruti Singh commonly perform?
Top Medicare-reported procedures in 2023: Injection, azacitidine, 1 mg (HCPCS J9025); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, aprepitant, 1 mg (HCPCS J0185). Source: CMS Medicare Physician & Other Practitioners file.